APOC3 and type 2 diabetes mellitus: The choice of protein was based on the observed up-regulation of apoCIII in the circulation in individuals with T2DM [9,13,14] and enhanced apoptosis in an insulin-secreting cell line exposed to the apolipoprotein [15].